Table 2 Demographic data of patients and controls.

From: Expression pattern of long non-coding RNAs in treatment-naïve and medicated schizophrenia patients

Study groups

Parameters

Values

Treatment-naive patients

Gender (number, %)

Male

20 (80%)

Female

5 (20%)

Age (Years, mean ± SD)

Male

27 ± 7.33

Female

24 ± 3.71

Family History (number, %)

Yes

15 (60%)

No

10 (40%)

Education (%)

Illiterate

40%

School

32%

High School

24%

University

4%

PANNS (mean ± SD)

72.52 ± 8.47

BPRS (mean ± SD)

51.16 ± 4.69

Positive symptoms score (mean ± SD)

17.12 ± 3.52

Negative symptoms score (mean ± SD)

16.84 ± 4.32

CRP (mg/L) (mean ± SD)

11.32 ± 3.23

Medicated Patients

Gender (number, %)

Male

42 (84%)

Female

8 (16%)

Age (Years, mean ± SD)

Male

42.26 ± 8.42

Female

37.33 ± 11.5

Age at onset (Years, mean ± SD)

Male

28.36 ± 6

Female

29 ± 3.6

Duration (Years, mean ± SD)

Male

14.45 ± 6.8

Female

8 ± 8.18

Family History (number, %)

Yes

27 (54%)

No

23 (46%)

Education (%)

Illiterate

20%

School

30%

High School

44%

University

6%

PANNS (mean ± SD)

58.12 ± 7.87

BPRS (mean ± SD)

33.62 ± 6.33

Positive symptoms score (mean ± SD)

12.86 ± 3.38

Negative symptoms score (mean ± SD)

10.68 ± 2.85

CRP (mg/L) (mean ± SD)

5.88 ± 2.22

Clozapine dose (mg/day) (mean ± SD)

172 ± 82.16

Controls

Gender (number, %)

Male

42 (84%)

Female

8 (16%)

Age (Years, mean ± SD (range))

Male

39.5 ± 8.81

Female

41 ± 9.51

Education (%)

Illiterate

0

School

10%

High School

48%

University

42%